The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective dynamic sampling and molecular residual disease monitoring to predict clinical outcomes for patients with unresectable, locally advanced non-small cell lung cancer undergoing radical radiotherapy.
 
Jia-Tao Zhang
No Relationships to Disclose
 
Yi Pan
No Relationships to Disclose
 
Xuan Gao
No Relationships to Disclose
 
Zhi-yong Chen
No Relationships to Disclose
 
Bingfa Yan
No Relationships to Disclose
 
Pei-Xin Tan
No Relationships to Disclose
 
Xiao-Rong Yang
No Relationships to Disclose
 
Hui Lin
No Relationships to Disclose
 
Hong-Hong Yan
No Relationships to Disclose
 
Song Dong
No Relationships to Disclose
 
Bin-Chao Wang
No Relationships to Disclose
 
Jin-Ji Yang
No Relationships to Disclose
 
Hai-Yan Tu
No Relationships to Disclose
 
Xue-Ning Yang
No Relationships to Disclose
 
Wenzhao Zhong
No Relationships to Disclose
 
Xuefeng Xia
No Relationships to Disclose
 
Xin Yi
No Relationships to Disclose
 
Qing Zhou
No Relationships to Disclose
 
Yi-Long Wu
Honoraria - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - BMS (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)